In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...
Living with ADHD can be overwhelming. From the constant distractions and struggles to focus to the impulsivity that disrupts everyday life, managing ADHD affects every corner of daily life for many ...
there are two central nervous system stimulant treatments licensed for the treatment of ADHD in children and adolescence, methylphenidate and dexamfetamine. The mode of action of the stimulants in ...
Objective Adherence to attention-deficit/hyperactivity disorder (ADHD) medication treatment is often suboptimal. This can compromise patient outcomes. We aimed to ...
For instance, as children, girls are diagnosed with ADHD half as often as boys ... to better understand coping strategies and treatment. "What is ADHD?” is a question that prompts many answers. One ...
He says it is a huge impost and he worries about families who cannot afford treatment for their children. GPs are advocating for a pilot program that will allow for ADHD diagnosis and treatment ...
Children’s Hospital of Nanjing Medical University, Nanjing, China Non-stimulant atomoxetine is recognized in various current clinical guidelines as an important alternative to stimulants for the ...